Why the study?
Malignant pleural effusion is a common clinical problem indicative of advanced cancer with high morbidity, mortality, and reduced therapeutic options.
Population
Patients with malignant pleural effusion
Design
Systematic review
Authors
Loading...
Indicates advanced disease with high morbidity; leaves open need for validated prognostic models and targeted therapies.
Malignant pleural effusion indicates advanced disease with a poor prognosis of 4-9 months, and management primarily focuses on palliation of dyspnoea.
Fausto Meriggi (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: